Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Foà R, Vitale A, Vignetti M, Meloni G, Guarini A, De Propris MS, Elia L, Paoloni F, Fazi P, Cimino G, Nobile F, Ferrara F, Castagnola C, Sica S, Leoni P, Zuffa E, Fozza C, Luppi M, Candoni A, Iacobucci I, Soverini S, Mandelli F, Martinelli G, Baccarani M; GIMEMA Acute Leukemia Working Party.
Blood. 2011 Dec 15;118(25):6521-8. doi: 10.1182/blood-2011-05-351403. Epub 2011 Sep 19.
Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemia.
Yuan J, Zhang J, Zhao B, Liu F, Liu T, Duan Y, Chen Y, Chen X, Zou Y, Zhang L, Guo Y, Yang W, Yang Y, Wei J, Zhu X, Zhang Y.
Cancer Lett. 2024 Aug 1;596:217018. doi: 10.1016/j.canlet.2024.217018. Epub 2024 Jun 4.
Lymphoblastic lymphoma.
Cortelazzo S, Ponzoni M, Ferreri AJ, Hoelzer D.
Crit Rev Oncol Hematol. 2011 Sep;79(3):330-43. doi: 10.1016/j.critrevonc.2010.12.003. Epub 2011 Jan 26.
CD99 in malignant hematopoiesis.
Ali A, Vaikari VP, Alachkar H.
Exp Hematol. 2022 Feb;106:40-46. doi: 10.1016/j.exphem.2021.12.363. Epub 2021 Dec 14.
Characterization of CD22 expression in acute lymphoblastic leukemia.
Shah NN, Stevenson MS, Yuan CM, Richards K, Delbrook C, Kreitman RJ, Pastan I, Wayne AS.
Pediatr Blood Cancer. 2015 Jun;62(6):964-9. doi: 10.1002/pbc.25410. Epub 2015 Mar 1.
Significance of CD66c expression in childhood acute lymphoblastic leukemia.
Kiyokawa N, Iijima K, Tomita O, Miharu M, Hasegawa D, Kobayashi K, Okita H, Kajiwara M, Shimada H, Inukai T, Makimoto A, Fukushima T, Nanmoku T, Koh K, Manabe A, Kikuchi A, Sugita K, Fujimoto J, Hayashi Y, Ohara A.
Leuk Res. 2014 Jan;38(1):42-8. doi: 10.1016/j.leukres.2013.10.008. Epub 2013 Oct 22.
PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia.
Xu X, Zhang W, Xuan L, Yu Y, Zheng W, Tao F, Nemechek J, He C, Ma W, Han X, Xie S, Zhao M, Wang J, Qu Y, Liu Q, Perry JM, Jiang L, Zhao M.
Nat Cell Biol. 2023 Jan;25(1):170-182. doi: 10.1038/s41556-022-01050-3. Epub 2023 Jan 9.
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.
Koller P, Baran N, Harutyunyan K, Cavazos A, Mallampati S, Chin RL, Jiang Z, Sun X, Lee HH, Hsu JL, Williams P, Huang X, Curran MA, Hung MC, Konopleva M.
J Immunother Cancer. 2023 Oct;11(10):e006619. doi: 10.1136/jitc-2022-006619.
Hyper-eosinophilia in granular acute B-cell lymphoblastic leukemia with myeloid antigen expression.
Kobayashi D, Kogawa K, Imai K, Tanaka T, Sada A, Nonoyama S.
Pediatr Int. 2012 Aug;54(4):543-6. doi: 10.1111/j.1442-200X.2011.03471.x.
Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangement.
Suematsu M, Yagyu S, Yoshida H, Osone S, Nakazawa Y, Sugita K, Imamura T, Iehara T.
Cancer Immunol Immunother. 2023 Apr;72(4):957-968. doi: 10.1007/s00262-022-03303-4. Epub 2022 Oct 10.
